CG Oncology, Inc.

Biological Products, (No Diagnostic Substances)·DALLAS, TX·FY end 12/31·CIK 1991792

Board of Directors

7 members · 6 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Arthur Kuan	CEO and Director	9y	35	—	—	—
Susan Graf	Director	3y	53	AuditNCG		—
Brian Liu	Director	4y	37	AuditComp		—
James J. Mulé	Director	8y	73	—		—
Leonard Post	Lead Independent Director	8y	73	CompNCG		—
Christina Rossi	Director	1y	50	Comp		—
Victor Tong, Jr.	Director	3y	42	NCGAudit		—

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.